Advancing Toward Multiple Sclerosis Therapies Using Stem Cells
Dr. Tom Lane of the University of Utah (formerly a CIRM grantee at UC-Irvine) describes his lab's experimental results that show a dramatic reversal in the debilitating effects of a multiple sclerosis (MS)-like illness in mice after treating them with human neural stem cells. After just two weeks, the mice—who had previously been unable to walk or even feed themselves—had regained basic motor skills. And six months later the improvements have only continued.
For more info about the the agency's MS research funding, visit our MS fact sheet.